Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

BioNovelus Receives Organic Certification for CR-10®


Posted on: 26 Apr 18

FOR IMMEDIATE RELEASE — Phoenix, April 26, 2018 (GLOBE NEWSWIRE) -- — BioNovelus is proud to announce that its flagship product CR-10®, a non-toxic, organic fungicide has received the organic certification from Mayacert.

Mayacert, the leading company in the certification of agricultural products, process, and systems, operates in the southern region of Mexico, Central America, and Colombia. For twenty years, Mayacert has been promoting certification services for small, medium and large agricultural producers, processors, and food exporters.

Mayacert Organic certification has a national and international recognition. It offers co-certification with most international organizations like USDA-Organic, Canada-Organic, EU-Organic, Japan JAS, UTZ-certified, and Organico SAGARPA Mexico.

“This certification is a big milestone for BioNovelus.” says BioNovelus’ Founder and CEO, Jean Ekobo. “Our team has worked for it diligently, and we have been waiting for this for quite a while! Farmers and food packers using CR-10® will now be in compliance with the various agencies’ organic standards for crops and coffees grown in Mexico, Central America, and Columbia. So far, there was a gap in biosecurity between the organic harvest and the post-harvest and shelf life of organic produce. CR-10® now fills the gap in the organic food chain by providing an effective tool to kill pathogens such as E-coli and Salmonella, the leading cause of billions of dollars of food recall.”

About BioNovelus:
BioNovelus is a bioscience company that honors the environment with innovative, cost-effective, and disruptive technology-based solutions to crop protection, food security, and health challenges.

About CR-10® Biofungicide
CR-10® Biofungicide is a proven, biodegradable, non-toxic solution that kills bacteria, fungi, and spores rapidly, safely and effectively. It is a new generation of biofungicide with a unique mode of action. BioNovelus management believes that CR-10® has a broad range of uses in crop protection before harvest, and in food security post-harvest.

Forward-Looking Statements
This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for the fiscal year 2018 and beyond could differ materially from the Company’s current expectations. Forward-looking statements are identified by words such as “anticipates,” “projects,” “expects,” “plans,” “intends,” “believes,” “estimates,” “targets,” and other similar expressions that indicate trends and future events.
Factors that could cause the Company’s results to differ materially from forward-looking statements regarding the success of the workshops and efficacy of the crop restoration and results of CR-10 include the lack of capital needed to complete testing, the lack of experience with pursuing approval of this product and modifications and receipt of information that may be demanded by the registration of the CR-10 formula and the delays in the various government approval processes unrelated to the product itself. Factors that could cause lower turn-out in the future include the cities we select to have our workshops and the interest in alternatives to existing products, rates of success in CR-10 eradication of fungi and bacteria include the method and timing of applications of CR-10, the impact of the strength of fungi and bacteria contamination, and other environmental conditions resulting in re-infection. Factors that may impact Guatemalan acceptance of our product include the compatibility with other chemical products.
There is no assurance of when all necessary registrations in Guatemala will be obtained for CR-10 Biofungicide and various applications as several field trials are still in progress. There is no assurance that the coffee rust application or any other crop protection or post-harvest protection applications will prove commercially viable. There is no assurance that any transaction will be done with Guatemalan distributors although we do have one distributor currently importing product to Guatemala.
Factors that could cause the Company’s results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, general business and economic conditions beyond the Company’s control the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, compatibility with other chemical products, the application of the products, and the Company’s success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements because of new information, since these statements may no longer be accurate or timely.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

— 30 —

CONTACT: Media contact: Nathalie Ekobo, Marketing & Communications Director BioNovelus, Inc. +1 888-924-6668 ext. 0 NEkobo@BioNovelus.com GlobeNewswire
globenewswire.com

Last updated on: 26/04/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.